CP and COVID-19: The impact and benefit of the use of CP as therapy against COVID-19 have been widely reported since the beginning of the pandemic [26]; however, the lack of established standard dosing methods, lack of the potent availability of donors, unknown host interactions, and severe adverse serum reactions have rendered CP therapy controversial and limited its applications [27].